4.43
price down icon4.73%   -0.22
after-market アフターアワーズ: 4.43
loading
前日終値:
$4.65
開ける:
$4.64
24時間の取引高:
3.85M
Relative Volume:
1.24
時価総額:
$709.51M
収益:
$181.41M
当期純損益:
$-59.56M
株価収益率:
-10.55
EPS:
-0.42
ネットキャッシュフロー:
$-38.83M
1週間 パフォーマンス:
-7.32%
1か月 パフォーマンス:
-5.94%
6か月 パフォーマンス:
+24.09%
1年 パフォーマンス:
+90.95%
1日の値動き範囲:
Value
$4.305
$4.66
1週間の範囲:
Value
$4.305
$5.105
52週間の値動き範囲:
Value
$2.03
$6.07

Xeris Biopharma Holdings Inc Stock (XERS) Company Profile

Name
名前
Xeris Biopharma Holdings Inc
Name
セクター
Healthcare (1170)
Name
電話
844-445-5704
Name
住所
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Name
職員
394
Name
Twitter
@XerisPharma
Name
次回の収益日
2024-12-08
Name
最新のSEC提出書
Name
XERS's Discussions on Twitter

XERS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
XERS
Xeris Biopharma Holdings Inc
4.43 765.54M 181.41M -59.56M -38.83M -0.42
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-11 ダウングレード Piper Sandler Overweight → Neutral
2024-03-28 開始されました Oppenheimer Outperform
2023-08-28 開始されました Craig Hallum Buy
2022-10-21 開始されました Jefferies Buy
2022-04-28 開始されました Craig Hallum Buy
2021-11-17 開始されました SVB Leerink Outperform
2021-10-29 開始されました H.C. Wainwright Buy
2021-04-07 再開されました RBC Capital Mkts Outperform
2020-02-18 開始されました Piper Sandler Overweight
2018-07-16 開始されました Jefferies Buy
2018-07-16 開始されました Leerink Partners Outperform
2018-07-16 開始されました RBC Capital Mkts Outperform
すべてを表示

Xeris Biopharma Holdings Inc (XERS) 最新ニュース

pulisher
01:20 AM

Transcript : Xeris Biopharma Holdings, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - marketscreener.com

01:20 AM
pulisher
Jun 04, 2025

Xeris at Jefferies Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

xeris biopharma holds annual meeting, elects directors - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Xeris Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Xeris Biopharma touts ambitious growth plan, promising hypothyroidism drug - Crain's Chicago Business

Jun 04, 2025
pulisher
Jun 03, 2025

Xeris Biopharma Holdings, Inc. Rings the Closing Bell - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

Transcript : Xeris Biopharma Holdings, Inc.Analyst/Investor Day - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Biopharma Holdings, Inc. Reaffirms Revenue Guidance for the Year 2025 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Biopharma projects $1 billion Recorlev revenue by 2035 - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Unveils Strategy for Long-Term Growth and Value Creation a - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Biopharma Holdings Reaffirms 2025 Revenue Guidance Of $260-$275 Million - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Stock Holdings Lessened by Ameriprise Financial Inc. - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

XERS: Key Highlights from Analyst and Investor Day | XERS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Cuts Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $273,000 Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Bank of America Corp DE Sells 17,544 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 31, 2025
pulisher
May 30, 2025

Deutsche Bank AG Grows Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 30, 2025
pulisher
May 28, 2025

Millennium Management LLC Raises Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 28, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Acquires Shares of 100,012 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 27, 2025
pulisher
May 25, 2025

Xeris Biopharma (NASDAQ:XERS) Cut to “Hold” at Wall Street Zen - Defense World

May 25, 2025
pulisher
May 23, 2025

Northern Trust Corp Purchases 38,155 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 23, 2025
pulisher
May 22, 2025

Xeris Biopharma Holdings Inc (XERS) With A Potential Upside Of More Than 18.7% - Stocksregister

May 22, 2025
pulisher
May 22, 2025

Jane Street Group LLC Decreases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 22, 2025
pulisher
May 20, 2025

Xeris Announces Details for Analyst & Investor Day | XERS Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Xeris Announces Details for Analyst & Investor Day - Business Wire

May 20, 2025
pulisher
May 20, 2025

Balyasny Asset Management L.P. Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 20, 2025
pulisher
May 19, 2025

The Manufacturers Life Insurance Company Lowers Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 19, 2025
pulisher
May 16, 2025

Leerink Partnrs Estimates Xeris Biopharma Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Voya Investment Management LLC Reduces Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 15, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Purchases New Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 15, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Decreases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 13, 2025
pulisher
May 13, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Position Raised by Price T Rowe Associates Inc. MD - Defense World

May 13, 2025
pulisher
May 12, 2025

Xeris Biopharma Holdings, Inc. (XERS): Among the Unstoppable Growth Stocks to Invest in Now - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives $6.10 Consensus Target Price from Analysts - Defense World

May 12, 2025
pulisher
May 11, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

May 11, 2025
pulisher
May 10, 2025

Xeris Biopharma Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Oppenheimer Increases Price Target for Xeris Biopharma (XERS) to $7 | XERS Stock News - GuruFocus

May 10, 2025
pulisher
May 09, 2025

XERS: Oppenheimer Raises Price Target for Xeris Biopharma Holdings | XERS Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Xeris Biopharma: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Xeris Biopharma Reports Record First Quarter 2025 Financial Results - BioSpace

May 09, 2025
pulisher
May 09, 2025

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highli - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Xeris Biopharma Reports Strong Q1 2025 Growth - TipRanks

May 09, 2025
pulisher
May 08, 2025

Xeris Pharmaceuticals Reports Strong Earnings and Growth - TipRanks

May 08, 2025
pulisher
May 08, 2025

Xeris Biopharma raises revenue guidance for 2025 to $260M-$275M amid strong Recorlev growth - MSN

May 08, 2025
pulisher
May 08, 2025

Xeris Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Transcript : Xeris Biopharma Holdings, Inc., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com

May 08, 2025

Xeris Biopharma Holdings Inc (XERS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
大文字化:     |  ボリューム (24 時間):